Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions.
about
The Non-coding Mammary Carcinoma Susceptibility Locus, Mcs5c, Regulates Pappa Expression via Age-Specific Chromatin Folding and Allele-Dependent DNA MethylationGrowth hormone and reproduction: a review of endocrine and autocrine/paracrine interactionsGrowth hormone is secreted by normal breast epithelium upon progesterone stimulation and increases proliferation of stem/progenitor cells.Lineage-specific restraint of pituitary gonadotroph cell adenoma growth.Insulin-like growth factor-I regulation of immune function: a potential therapeutic target in autoimmune diseases?IGF-I during primiparous pregnancy and maternal risk of breast cancerA moderate elevation of circulating levels of IGF-I does not alter ErbB2 induced mammary tumorigenesisMammary gland growth factors: roles in normal development and in cancer.Insulin-mediated acceleration of breast cancer development and progression in a nonobese model of type 2 diabetesGrowth hormone potentiates 17β-estradiol-dependent breast cancer cell proliferation independently of IGF-I receptor signaling.Interactions between vitamin D and IGF-I: from physiology to clinical practice.Elevated circulating IGF-I promotes mammary gland development and proliferation.t10,c12-CLA decreases adiposity in peripubertal mice without dose-related detrimental effects on mammary development, inflammation status, and metabolismElevated GH/IGF-I promotes mammary tumors in high-fat, but not low-fat, fed miceDistinct luminal-type mammary carcinomas arise from orthotopic Trp53-null mammary transplantation of juvenile versus adult mice.Growth hormone signaling in human T47D breast cancer cells: potential role for a growth hormone receptor-prolactin receptor complexInsulin-like growth factor-I inhibition with pasireotide decreases cell proliferation and increases apoptosis in pre-malignant lesions of the breast: a phase 1 proof of principle trial.Expression of IGF1R in normal breast tissue and subsequent risk of breast cancerLactogens and estrogens in breast cancer chemoresistance.Association of polymorphisms and haplotypes in the insulin-like growth factor 1 receptor (IGF1R) gene with the risk of breast cancer in Korean women.Effects of Tai Chi Chuan on insulin and cytokine levels in a randomized controlled pilot study on breast cancer survivors.Obesity alters gene expression for GH/IGF-I axis in mouse mammary fat pads: differential role of cortistatin and somatostatin.Circulating estrogens and progesterone during primiparous pregnancies and risk of maternal breast cancer.Environmental exposures and mammary gland development: state of the science, public health implications, and research recommendations.Mammary tumors that become independent of the type I insulin-like growth factor receptor express elevated levels of platelet-derived growth factor receptors.The dog as a naturally-occurring model for insulin-like growth factor type 1 receptor-overexpressing breast cancer: an observational cohort study.Chemoprevention of hormone receptor-negative breast cancer: new approaches neededFetal alcohol exposure increases mammary tumor susceptibility and alters tumor phenotype in rats.A novel long noncoding RNA IRAIN regulates cell proliferation in non small cell lung cancer.Epithelial protein-tyrosine phosphatase 1B contributes to the induction of mammary tumors by HER2/Neu but is not essential for tumor maintenance.Peptide receptor targeting in cancer: the somatostatin paradigm.Lack of cortistatin or somatostatin differentially influences DMBA-induced mammary gland tumorigenesis in mice in an obesity-dependent mode.Effects of exercise intervention in breast cancer survivors: a meta-analysis of 33 randomized controlled trails.Two birds with one stone: octreotide treatment for acromegaly and breast cancer.Growth hormone is permissive for neoplastic colon growth.Transgenic insulin-like growth factor-1 stimulates activation of COX-2 signaling in mammary glands.Molecular mechanisms controlling E-cadherin expression in breast cancer.Characterization of preneoplastic and neoplastic rat mesothelial cell lines: the involvement of TETs, DNMTs, and 5-hydroxymethylcytosine.A multiantigen vaccine targeting neu, IGFBP-2, and IGF-IR prevents tumor progression in mice with preinvasive breast disease.Pubertal high fat diet: effects on mammary cancer development.
P2860
Q27308041-47EBE744-208C-40C0-98E0-D11B29C62AC9Q28082801-5D86AF05-2BB6-406A-9976-8EBE4FB5DD93Q33729654-4E2C6A64-F6E5-45FE-8E96-B41A451D1FF8Q33862684-776FEE2E-B0D3-48E9-90FE-2FE231B033BAQ33890792-6E7BEE00-56F1-462C-AD8A-4635A9B642ABQ33916778-F7BEBDA9-1394-4347-89B2-114283A939CEQ34002933-7BACF6C8-A6C1-4F17-B134-F64CFBD403CCQ34014659-11B8D594-973E-42F1-8ED6-90B796D189BFQ34157626-0CA36AC2-014D-406C-A518-125426D98BDBQ34352011-E3483FD3-3651-4A41-8DF7-13E6A83FBC17Q34352477-2B94D21B-BB8E-425A-A809-83DBAC579944Q34392686-AF94D9D7-4F79-4FA7-A44E-77AF603023F5Q34429126-020B167E-59D9-443D-AFDB-2926668E3A5CQ34434910-53100C01-04DA-4D7E-9F7B-8D7716AE1D58Q34616600-3C4879DC-DA9A-491F-BA24-2328B45AC797Q34712091-E5DE928D-5BA0-49AD-BE96-233F32C7401AQ35000609-363FE108-CBEA-4C11-B9E8-C37CC6AEB4C3Q35048307-E0EA0185-16A5-4910-B6A3-6C5BC539532FQ35075176-DD77F2B4-E0A4-4533-B099-C6600ADC8248Q35083425-54FC1826-1A96-4021-9752-985700544870Q35166021-2A1CEF69-00C8-47C3-80AB-49828CA382C5Q35217246-A483BC6D-2DB2-479A-9B28-0D009AC9D4DDQ35291547-D46FE1A9-16A4-4F4C-A0B8-FC437CC3F9F7Q35611293-8CA5143F-F408-47ED-A936-8CB45CADD22AQ35661710-77C186E4-390A-489B-9E38-23283BD89011Q36139739-F7E24990-272B-48C1-8257-4C40F082C759Q36153371-5BDC0CA6-7D30-40FC-B67F-EDF3A0442513Q36251216-4659BD1B-0CEC-4AE5-BED9-48507684ABE9Q36375083-36B2EC33-6EC9-47DB-AA32-FDA618CD1C13Q36634268-BCF7BCA4-7623-4703-90BE-1C561DCEEFDBQ36638046-81609A1E-DA4F-40DC-8C45-FC07A48518E2Q36662452-33D084EA-FFE3-4F09-B631-8CD13C79A84CQ36808182-91959CD5-70E8-459F-8C26-307FE8B74104Q36929849-3401979E-AA57-46B6-9936-442505726EDBQ37183586-9E30B26D-A685-486C-9F19-E6F12DC264F2Q37215586-66490D8C-0356-4D18-9482-1042054E77B0Q37238311-91A1DB19-29BC-4A51-A780-15B63D76E4C5Q37376365-9729A347-08BE-4059-A185-38E2DD9F912EQ37396281-0F084E90-0FDA-4128-91E4-E667E1EC8382Q37690070-BCB6B29F-FC8F-421B-9DE5-8818925655C8
P2860
Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions.
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
Growth hormone and insulin-lik ...... preneoplastic mammary lesions.
@ast
Growth hormone and insulin-lik ...... preneoplastic mammary lesions.
@en
Growth hormone and insulin-lik ...... preneoplastic mammary lesions.
@nl
type
label
Growth hormone and insulin-lik ...... preneoplastic mammary lesions.
@ast
Growth hormone and insulin-lik ...... preneoplastic mammary lesions.
@en
Growth hormone and insulin-lik ...... preneoplastic mammary lesions.
@nl
prefLabel
Growth hormone and insulin-lik ...... preneoplastic mammary lesions.
@ast
Growth hormone and insulin-lik ...... preneoplastic mammary lesions.
@en
Growth hormone and insulin-lik ...... preneoplastic mammary lesions.
@nl
P2093
P2860
P356
P1433
P1476
Growth hormone and insulin-lik ...... preneoplastic mammary lesions.
@en
P2093
Adrian V Lee
David L Kleinberg
Priscilla A Furth
Teresa L Wood
P2860
P356
10.1210/ER.2008-0022
P577
2008-12-15T00:00:00Z